Rein Therapeutics, Inc. Annual Return On Assets in % from 2018 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Rein Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2018 to 2024.
  • Rein Therapeutics, Inc. Return On Assets for the quarter ending December 31, 2024 was -67.1 %, a 59.9% decline year-over-year.
  • Rein Therapeutics, Inc. annual Return On Assets for 2024 was -67.1 %, a 59.9% decline from 2023.
  • Rein Therapeutics, Inc. annual Return On Assets for 2023 was -42 %, a 52.7% increase from 2022.
  • Rein Therapeutics, Inc. annual Return On Assets for 2022 was -88.7 %, a 93.6% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -67.1 -25.1 -59.9% Jan 1, 2024 Dec 31, 2024
2023 -42 +46.7 +52.7% Jan 1, 2023 Dec 31, 2023
2022 -88.7 -42.9 -93.6% Jan 1, 2022 Dec 31, 2022
2021 -45.8 +82.7 +64.3% Jan 1, 2021 Dec 31, 2021
2020 -128 -33 -34.5% Jan 1, 2020 Dec 31, 2020
2019 -95.5 -15.1 -18.7% Jan 1, 2019 Dec 31, 2019
2018 -80.5 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.